cutaneous lupus erythematosus

AstraZeneca receives EU approval for its Saphnelo, the only new medicine in over a decade for patients with systemic lupus erythematosus

(PRESS RELEASE) CAMBRIDGE, 16-Feb-2022 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced an…

2 years ago

The only new medicine in over a decade for patients with systemic lupus erythematosus gets Food and Drug Administration (FDA) approval

(PRESS RELEASE) CAMBRIDGE, 2-Aug-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish science-led biopharmaceutical company, has announced that its Saphnelo…

3 years ago